Scleromyxedema, a therapeutic dilemma
- ,
- Brayant Martinez-Jaramillo,
- Minerva Gomez-Flores,
- Jorge Ocampo-Candiani
- Universidad Autonoma de Nuevo Leon
Research Output:
Contribution to journal
Article
Peer-reviewPublication metrics
Metrics
SciVal
Citations
11
SciVal
FWCI
0.87
SciVal
Author count
4
SciVal
Paper percentile
68
Abstract
Scleromyxedema is characterized by indurated erythematous papules disseminated on the face, chest and limbs. About twenty cases treated with thalidomide, stem cells, melphalan and immunoglobulin with varying results have been described. We present the case of a 28-year-old male patient diagnosed with scleromyxedema not associated with monoclonal gammopathy, multi-treated with anti-leprosy drugs, UVA1, and thalidomide for 4 years with no improvement.
Publication Information
Output type
Research Output:
Contribution to journal
Article
Peer-reviewOriginal language
EnglishPages from-to (Number of pages)
Page 215 (1 page)Journal (Volume, Issue Number)
Indian Journal of Dermatology (Volume 60, Issue 2)Publication milestones
- Published - 01/04/2015
Publication status
Published - 01/04/2015
ISSN
0019-5154Publication IDs
- Scopus: 84925402645
- PubMed: 25814746
- WOS: 000385034900050